RBPE backs Expamet public-to-private offer

The group’s independent directors have recommended that shareholders accept the offer, saying it gives ‘the certainty of a cash offer now versus the uncertainty of an increase in shareholder value over time in challenging market conditions'.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this